+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Enuresis alarm treatment as a second line to pharmacotherapy in children with monosymptomatic nocturnal enuresis



Enuresis alarm treatment as a second line to pharmacotherapy in children with monosymptomatic nocturnal enuresis



Journal of Urology 171(6 Pt 2): 2615-2617



Purpose: We evaluate the effectiveness of enuresis alarm as second line therapy for partial or nonresponders to pharmacotherapy. Materials and Methods: We recommended enuresis alarm treatment for 67 partial or nonresponders to pharmacotherapy for monosymptomatic nocturnal enuresis. Of these patients 28 were evaluable by inclusion and exclusion criteria. We analyzed the effectiveness of enuresis alarm therapy using the response criteria defined by the reduction rate of wet nights, defined as complete response (greater than 90%), partial response (50% to 90%) and no response (less than 50%). We defined initial and lasting cure when patients showed persistent full response for 4 weeks and 6 months after cessation of all treatments, respectively. Results: After pharmacotherapy partial responders showed a mean response of 81.2%. On the other hand, nonresponders exhibited a mean response of 26.4% with more than 20 wet nights in 4 weeks. After using second line enuresis alarm treatment 90.5% (19 of 21) of partial responders became full responders and 71.4% (15 of 21), 61.9% (13 of 21) of partial responders showed initial and lasting cure, respectively. In addition, 71.4% (5 of 7) of nonresponders became full responders and 57.1% (4 of 7) exhibited initial and lasting cure. Conclusions: Enuresis alarm as second line therapy for monosymptomatic nocturnal enuresis is effective for lasting cure as well as high initial full response rate in partial and nonresponders to pharmacotherapy. Therefore, enuresis alarm is a reasonable second line therapeutic option for partial or nonresponders to pharmacotherapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012042569

Download citation: RISBibTeXText

PMID: 15118432

DOI: 10.1097/01.ju.0000113036.13536.29


Related references

Role of Urodynamic Study in Nocturnal Enuresis: Urodynamic Findings and Treatment Outcome Correlation in Children with Pharmacotherapy-resistant Monosymptomatic Nocturnal Enuresis or Severe Non-monosymptomatic Nocturnal Enuresis. Lower Urinary Tract Symptoms 6(2): 88-93, 2014

Efficacy of desmopressin and enuresis alarm as first and second line treatment for primary monosymptomatic nocturnal enuresis: prospective randomized crossover study. Journal of Urology 184(6): 2521-2526, 2010

Efficacy of an enuresis alarm, desmopressin, and combination therapy in the treatment of saudi children with primary monosymptomatic nocturnal enuresis. Korean Journal of Urology 54(11): 783-790, 2013

Is second-line enuretic alarm therapy after unsuccessful pharmacotherapy superior to first-line therapy in the treatment of monosymptomatic nocturnal enuresis?. Urologia Internationalis 78(3): 260-263, 2007

The efficacy of enuresis alarm treatment in pharmacotherapy-resistant nocturnal enuresis. Urology 77(1): 200-204, 2011

The efficacy of an enuresis alarm in monosymptomatic nocturnal enuresis. Singapore Medical Journal 50(9): 879-880, 2009

The effect of alarm treatment on the functional bladder capacity in children with monosymptomatic nocturnal enuresis. Journal of Urology 171(6 Pt 2): 2611-2614, 2004

Combination of the enuresis alarm and desmopressin: second line treatment for nocturnal enuresis. Journal of Urology 179(3): 1128-1131, 2008

Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: an open multicentre study. Swedish Enuresis Trial (SWEET) Group. British Journal of Urology 82(5): 704-709, 1998

Improving the cure rate of alarm treatment for monosymptomatic nocturnal enuresis by increasing bladder capacity - A randomized controlled trial in children. Journal of Urology 179(3): 1122-1126, 2008

The optimal duration of alarm therapy use in children with primary monosymptomatic nocturnal enuresis. Journal of Pediatric Urology 14(5): 447.E1-447.E6, 2018

Family compliance with the use of alarm devices in the treatment of monosymptomatic nocturnal enuresis. Turkish Journal of Urology 40(1): 52-55, 2014

Melatonin production is similar in children with monosymptomatic nocturnal enuresis or other forms of enuresis/incontinence and in controls. Journal of Urology 166(6): 2407-2410, 2001

Anticholinergics do not improve cure rate of alarm treatment of monosymptomatic nocturnal enuresis. Urology 77(3): 721-724, 2011

Effect of alarm treatment on bladder storage capacities in monosymptomatic nocturnal enuresis. Scandinavian Journal of Urology and Nephrology 38(3): 207-210, 2004